Stammdaten
Unternehmen
| Name | Heartflow, Inc. |
|---|---|
| Ticker | HTFL |
| CIK | 0001464521 |
Branche
| SIC-Code | 3841 |
|---|---|
| Beschreibung | Surgical & Medical Instruments & Apparatus |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Heartflow, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 10:13:27.432739 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 176,034,000 | -116,791,000 | -3.17 | 359,452,000 | 300,647,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | Rogers Campbell | Officer, Chief Medical Officer | Open Market Sale | -64,533 | 25.69 | -1,658,033.46 | -40,0% | |
| 2026-03-18 | Farquhar John C.M. | Director, Officer, Chief Executive Officer | Open Market Sale | -9,725 | 25.00 | -243,125.00 | -5,9% | |
| 2026-03-18 | Farquhar John C.M. | Director, Officer, Chief Executive Officer | Open Market Sale | -9,725 | 25.00 | -243,125.00 | -5,9% | |
| 2026-03-10 | Farquhar John C.M. | Director, Officer, Chief Executive Officer | Open Market Sale | -12,837 | 22.66 | -290,886.42 | -7,0% | |
| 2026-03-10 | Farquhar John C.M. | Director, Officer, Chief Executive Officer | Open Market Sale | -12,837 | 22.66 | -290,886.42 | -7,0% | |
| 2026-03-05 | Cullivan Julie A | Director | Open Market Sale | -9,122 | 25.00 | -228,050.00 | -5,5% | |
| 2026-03-05 | Cullivan Julie A | Director | Open Market Sale | -9,122 | 25.00 | -228,050.00 | -5,5% | |
| 2026-02-12 | Rogers Campbell | Officer, Chief Medical Officer | Open Market Sale | -65,153 | 24.49 | -1,595,486.21 | -38,5% | |
| 2026-02-12 | Rogers Campbell | Officer, Chief Medical Officer | Open Market Sale | -65,153 | 24.49 | -1,595,486.21 | -38,5% | |
| 2026-02-10 | Farquhar John C.M. | Director, Officer, Chief Executive Officer | Open Market Sale | -22,562 | 27.46 | -619,552.52 | -15,0% | |
| 2026-02-10 | Farquhar John C.M. | Director, Officer, Chief Executive Officer | Open Market Sale | -22,562 | 27.46 | -619,552.52 | -15,0% | |
| 2026-02-05 | Cullivan Julie A | Director | Open Market Sale | -8,000 | 27.32 | -218,560.00 | -5,3% | |
| 2026-02-05 | Cullivan Julie A | Director | Open Market Sale | -8,000 | 27.32 | -218,560.00 | -5,3% | |
| 2026-02-04 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Open Market Sale | -2,000,000 | 28.05 | -56,100,000.00 | -1354,7% | |
| 2025-12-16 | Lightcap Jeffrey C | Director | Open Market Purchase | 40,000 | 26.34 | 1,053,680.00 | +25,4% | |
| 2025-12-16 | Lightcap Jeffrey C | Director | Open Market Purchase | 40,000 | 26.34 | 1,053,680.00 | +25,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.